Pete De Spain | VP, IR and Corporate Communications |
Troy Wilson | President and CEO |
Marc Grasso | CFO and Chief Business Officer |
Antonio Gualberto | Head, Development and Chief Medical Officer |
Jonathan Chang | STB Leerink |
Pamela Barendt | Cowen |
Alexander Duncan | Piper Jaffray |
Jay Olson | Oppenheimer |
Joel Beatty | Citi |
Good day, ladies and gentlemen, and welcome to the Fourth Quarter 2018 Kura Oncology Incorporated Earnings Conference Call. [Operator Instructions] As a reminder, this call may be recorded. I would now like to introduce your host for today's conference, Pete De Spain, Vice President, Investor Relations. Sir, you may begin.
Thank you, Heather.